Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology
Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent
Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects
Discovery of Soluble Epoxide Hydrolase Inhibitors from Chemical
Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent
Inhibition of soluble epoxide hydrolase alleviates insulin
Therapeutic and Prognostic Significance of Arachidonic Acid in
Cardiomyocyte-specific disruption of soluble epoxide hydrolase
PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and
Inhibition of soluble epoxide hydrolase alleviates insulin
Cardiomyocyte-specific disruption of soluble epoxide hydrolase
High-fat feeding in cardiomyocyte-restricted PPARδ knockout mice
A novel soluble epoxide hydrolase vaccine protects murine cardiac